Skip to main content
Clinical Trials/NCT05379348
NCT05379348
Active, not recruiting
Not Applicable

Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease

AdventHealth Translational Research Institute1 site in 1 country1,423 target enrollmentMarch 14, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer Disease
Sponsor
AdventHealth Translational Research Institute
Enrollment
1423
Locations
1
Primary Endpoint
Quantify the proportion of individuals at least 65 years old with cognitive impairment
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to investigate how we can detect Alzheimer's disease early by using an online memory test and a simple blood test. These new methods for early diagnosis could allow people to begin treatment sooner, with the potential to improve the lives of millions of people.

Registry
clinicaltrials.gov
Start Date
March 14, 2022
End Date
December 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
AdventHealth Translational Research Institute
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Quantify the proportion of individuals at least 65 years old with cognitive impairment

Time Frame: Less than 6 months

Study Sites (1)

Loading locations...

Similar Trials